Mindset Health

mindsethealth.com →

+73%

est. 2Y upside i

HealthcareSeries A

Building AI therapeutics for physical health conditions like IBS.

Rank

#1234

Sector

Digital Health

Est. Liquidity

~4Y

Data Quality

Data: Medium

Mindset Health presents a moderate upside opportunity driven by its strong competitive moat in clinically validated digital hypnotherapy and a rapidly growing market.

Last updated: March 10, 2026

Bull (23%)+300%

Mindset Health leverages its strong clinical evidence and proprietary gut-brain therapy dataset to become a dominant player in specialized digital therapeutics. Strategic partnerships with major healthcare providers or insurers drive rapid user acquisition and expand into new chronic conditions, pushing valuation to $208M (4x current) by 2028-2029.

Base (42%)+75%

Mindset Health continues to grow steadily within its niche markets like IBS and menopause, maintaining its differentiation against broader meditation apps. It successfully raises a Series B, expands its product offerings, and achieves a valuation of $91M (1.75x current) through continued subscriber growth and clinical validation, leading to a potential acquisition.

Bear (35%)-80%

Increased competition from well-funded direct competitors like HelloBetter and expansion by incumbents into specialized digital therapeutics lead to slower-than-expected user growth and pricing pressure. The company struggles to raise its next funding round, resulting in a down round or acquisition at a significantly reduced valuation of $10.4M, effectively wiping out most or all common stock value due to liquidation preferences.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

38%

Investors hold $20M in liquidation preferences. In an exit at or below $20M, common shareholders would receive nothing. At the current $52M valuation, investors would take $20M, leaving $32M for common shareholders.

Dilution Risk

high

As a Series A company, Mindset Health will likely need to raise additional funding rounds (Series B, C, etc.), which will dilute existing common stock holdings.

Secondary Liquidity

none

There is no indication of an active secondary market or tender offers for a Series A company of this size.

View all 3 open roles at Mindset Health →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Mindset Health's data — designed to show you've done your homework.

  • 1

    “How does Mindset Health plan to maintain its competitive edge and proprietary dataset advantage as larger digital health platforms or even big tech companies potentially move into specialized digital therapeutics?”

  • 2

    “With 31,000 paid monthly subscribers, what is the strategy for accelerating user acquisition and converting clinical validation into broader market penetration to justify future valuation increases?”

  • 3

    “Given the Series A funding and the typical runway, what is the company's projected timeline for the next funding round, and how is the team thinking about managing dilution for early employees?”

Community

Valuation Sentiment

Our model estimates +73% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.